Department of Laboratory Medicine, Clinical Center, National Institutes of Health, Bethesda, Maryland, USA.
Department of Medicine, University of Maryland School of Medicine, Baltimore, Maryland, USA.
Infect Immun. 2021 Sep 16;89(10):e0030121. doi: 10.1128/IAI.00301-21. Epub 2021 Jun 7.
Recent studies suggest an anti-inflammatory protective role for class B scavenger receptor BI (SR-BI) in endotoxin-induced inflammation and sepsis. Other data, including ours, provide evidence for an alternative role of SR-BI, facilitating bacterial and endotoxin uptake and contributing to inflammation and bacterial infection. Enhanced endotoxin susceptibility of SR-BI-deficient mice due to their anti-inflammatory glucocorticoid deficiency complicates the understanding of SR-BI's role in endotoxemia/sepsis, calling for the use of alternative models. In this study, using human SR-BI (hSR-BI) and hSR-BII transgenic mice, we found that SR-BI and, to a lesser extent, its splicing variant SR-BII protect against LPS-induced lung damage. At 20 h after intratracheal LPS instillation, the extent of pulmonary inflammation and vascular leakage was significantly lower in hSR-BI and hSR-BII transgenic mice than in wild-type mice. Higher bronchoalveolar lavage fluid (BALF) inflammatory cell count and protein content and lung tissue neutrophil infiltration found in wild-type mice were associated with markedly (2 to 3 times) increased proinflammatory cytokine production compared to these parameters in transgenic mice following LPS administration. The markedly lower endotoxin levels detected in BALF of transgenic versus wild-type mice and the significantly increased BODIPY-LPS uptake observed in lungs of hSR-BI and hSR-BII mice 20 h after the i.t. LPS injection suggest that hSR-BI- and hSR-BII-mediated enhanced LPS clearance in the airways could represent the mechanism of their protective role against LPS-induced acute lung injury.
最近的研究表明,B 类清道夫受体 BI(SR-BI)在内毒素诱导的炎症和败血症中具有抗炎保护作用。其他数据,包括我们的研究结果,提供了 SR-BI 的替代作用的证据,即促进细菌和内毒素摄取,并有助于炎症和细菌感染。由于缺乏抗炎性糖皮质激素,SR-BI 缺乏的小鼠对内毒素的敏感性增强,这使得我们对内毒素血症/败血症中 SR-BI 作用的理解变得复杂,需要使用替代模型。在这项研究中,我们使用人源 SR-BI(hSR-BI)和 hSR-BII 转基因小鼠发现,SR-BI 和其剪接变体 SR-BII 均可抵抗 LPS 诱导的肺损伤。在气管内 LPS 滴注 20 小时后,与野生型小鼠相比,hSR-BI 和 hSR-BII 转基因小鼠的肺部炎症和血管渗漏程度明显降低。在野生型小鼠中发现的支气管肺泡灌洗液(BALF)中炎症细胞计数和蛋白含量较高,肺组织中性粒细胞浸润与 LPS 给药后转基因小鼠中这些参数相比,明显增加了促炎细胞因子的产生。与野生型小鼠相比,BALF 中转基因小鼠中的内毒素水平明显降低,并且在 i.t. LPS 注射后 20 小时观察到 hSR-BI 和 hSR-BII 小鼠肺部的 BODIPY-LPS 摄取明显增加,表明 hSR-BI 和 hSR-BII 介导的 LPS 在气道中的清除增强可能是其抵抗 LPS 诱导的急性肺损伤的保护作用机制。